Dr. Hans Gritsch, MD

Dr. Gritsch practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Gritsch's NPI, 1720006976, was assigned on July 17, 2006. Dr. Gritsch graduated from Georgetown University School Of Medicine in 1985. Dr. Gritsch holds California license G59082.

Dr. Gritsch's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Gritsch's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Gritsch is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Gritsch to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gritsch practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gritsch's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gritsch is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gritsch's licenses on file in 4 states: California, New York, Florida and Pennsylvania.

Dmand AI lists kidney removal surgery, kidney transplant and urinary endoscopy among the conditions Dr. Gritsch treats.

CMS data shows 81 Medicare services from Dr. Gritsch across 4 procedure codes in 2024, for 48 Medicare patients. Medicare paid $75,988 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Gritsch in 2024. The largest group is under 65, with 30 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 54% are also on Medicaid. Their average risk score is 9.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gritsch's median patient age at 52, with 41% women.

In 2020, Dr. Gritsch wrote 20 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $149 in total drug cost. In 2019, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gritsch for performance year 2024, reported as part of a group. Dr. Gritsch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Gritsch in 2017. Dr. Gritsch's most frequent co-authors are Vatche Garen Agopian, MD, Adam Seth Bodzin, MD and Ronald W. Busuttil, MD.

Dmand AI links Dr. Gritsch to 1 clinical trial. Conditions studied include Sexual Behavior and Patient Satisfaction.

CMS Open Payments shows 26 general payments to Dr. Gritsch from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Sanofi and Genzyme US Companies paid the most, $283.

Dmand AI lists 2 awards for Dr. Gritsch.

Dr. Gritsch graduated from Georgetown University School Of Medicine in 1985. Dr. Gritsch is a member of ACS, American Society of Transplant Surgeons, AUA and Urological Society for Transplantation and Renal Surgery.

Dr. Gritsch is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.